Skip to main content
. Author manuscript; available in PMC: 2015 Feb 27.
Published in final edited form as: J Am Coll Cardiol. 2011 Jan 18;57(3):366–375. doi: 10.1016/j.jacc.2010.07.045

Figure 5. Effects of Ranolazine on Maximum Rate of Phase-Zero Action Potential Depolarization (dV/Dtmax) of Phase Zero Action Potential, Conduction Velocity, and Cai2+ Transient Decline Rate Constant (τ).

Figure 5

(A) Ranolazine causing rate-dependent significant decrease in dV/Dtmax at faster pacing cycle length (PCL) (<130 ms). (B, left) Isochronal activation maps with a color code (right) during pacing from the base at a PCL of 200 ms under different conditions. (C) H2O2 prolongs τ, whereas ranolazine (10 μM) has no effect on τ either before or after H2O2, as shown by the adjoining superimposed Cai2+ transients.